← FDA DRUG APPROVALS

FDA ANDA · ANDA078845

LINEZOLID

Sponsor: RISING

APPLICATION
ANDA078845
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-21
LATEST ACTION
2025-02-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

LINEZOLIDPrescription
LINEZOLID 600MG · TABLET · ORAL

Approval history

2025-02-14Labeling · Supplement 7 · standardAP
2025-02-14Labeling · Supplement 5 · standardAP
2025-02-14Labeling · Supplement 4 · standardAP
2019-02-12Labeling · Supplement 1 · standardAP
2019-02-12Labeling · Supplement 2 · standardAP
2015-12-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →